261 related articles for article (PubMed ID: 33235318)
1. The disubstituted adamantyl derivative LW1564 inhibits the growth of cancer cells by targeting mitochondrial respiration and reducing hypoxia-inducible factor (HIF)-1α accumulation.
Kim I; Kim M; Park MK; Naik R; Park JH; Kim BK; Choi Y; Chang KY; Won M; Ban HS; Lee K
Exp Mol Med; 2020 Nov; 52(11):1845-1856. PubMed ID: 33235318
[TBL] [Abstract][Full Text] [Related]
2. The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growth.
Ban HS; Kim BK; Lee H; Kim HM; Harmalkar D; Nam M; Park SK; Lee K; Park JT; Kim I; Lee K; Hwang GS; Won M
Cell Death Dis; 2017 Jun; 8(6):e2843. PubMed ID: 28569777
[TBL] [Abstract][Full Text] [Related]
3. A Novel Malate Dehydrogenase 2 Inhibitor Suppresses Hypoxia-Inducible Factor-1 by Regulating Mitochondrial Respiration.
Ban HS; Xu X; Jang K; Kim I; Kim BK; Lee K; Won M
PLoS One; 2016; 11(9):e0162568. PubMed ID: 27611801
[TBL] [Abstract][Full Text] [Related]
4. Licochalcone A inhibits hypoxia-inducible factor-1α accumulation by suppressing mitochondrial respiration in hypoxic cancer cells.
Park MK; Ji J; Haam K; Han TH; Lim S; Kang MJ; Lim SS; Ban HS
Biomed Pharmacother; 2021 Jan; 133():111082. PubMed ID: 33378978
[TBL] [Abstract][Full Text] [Related]
5. Vosaroxin induces mitochondrial dysfunction and apoptosis in cervical cancer HeLa cells: Involvement of AMPK/Sirt3/HIF-1 pathway.
Zhao XL; Yu CZ
Chem Biol Interact; 2018 Jun; 290():57-63. PubMed ID: 29800573
[TBL] [Abstract][Full Text] [Related]
6. The lignan manassantin is a potent and specific inhibitor of mitochondrial complex I and bioenergetic activity in mammals.
Ma Y; Min HK; Oh U; Hawkridge AM; Wang W; Mohsin AA; Chen Q; Sanyal A; Lesnefsky EJ; Fang X
J Biol Chem; 2017 Dec; 292(51):20989-20997. PubMed ID: 29046352
[TBL] [Abstract][Full Text] [Related]
7. TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation.
Chen Y; Liu L; Xia L; Wu N; Wang Y; Li H; Chen X; Zhang X; Liu Z; Zhu M; Liao Q; Wang J
J Exp Clin Cancer Res; 2022 Jan; 41(1):44. PubMed ID: 35101076
[TBL] [Abstract][Full Text] [Related]
8. Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1α in cancer cells.
Kim KK; Abelman S; Yano N; Ribeiro JR; Singh RK; Tipping M; Moore RG
Sci Rep; 2015 Oct; 5():14296. PubMed ID: 26469226
[TBL] [Abstract][Full Text] [Related]
9. NNC 55-0396, a T-type Ca2+ channel inhibitor, inhibits angiogenesis via suppression of hypoxia-inducible factor-1α signal transduction.
Kim KH; Kim D; Park JY; Jung HJ; Cho YH; Kim HK; Han J; Choi KY; Kwon HJ
J Mol Med (Berl); 2015 May; 93(5):499-509. PubMed ID: 25471482
[TBL] [Abstract][Full Text] [Related]
10. Sestrin2 inhibits hypoxia-inducible factor-1α accumulation via AMPK-mediated prolyl hydroxylase regulation.
Seo K; Seo S; Ki SH; Shin SM
Free Radic Biol Med; 2016 Dec; 101():511-523. PubMed ID: 27840318
[TBL] [Abstract][Full Text] [Related]
11. Cucurbitacin B inhibits the translational expression of hypoxia-inducible factor-1α.
Ma J; Zi Jiang Y; Shi H; Mi C; Li J; Xing Nan J; Wu X; Joon Lee J; Jin X
Eur J Pharmacol; 2014 Jan; 723():46-54. PubMed ID: 24333213
[TBL] [Abstract][Full Text] [Related]
12. Capsaicin inhibits HIF-1α accumulation through suppression of mitochondrial respiration in lung cancer cells.
Han TH; Park MK; Nakamura H; Ban HS
Biomed Pharmacother; 2022 Feb; 146():112500. PubMed ID: 34891118
[TBL] [Abstract][Full Text] [Related]
13. Methylalpinumisoflavone inhibits hypoxia-inducible factor-1 (HIF-1) activation by simultaneously targeting multiple pathways.
Liu Y; Veena CK; Morgan JB; Mohammed KA; Jekabsons MB; Nagle DG; Zhou YD
J Biol Chem; 2009 Feb; 284(9):5859-68. PubMed ID: 19091749
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis and Structure-Activity Relationship Studies of Novel 4 (1-adamantyl) Phenyl Analogues as HIF-1α Inhibitors.
Xia Y; Duan Q; Zhao BH; Li DF; Hou RB
Med Chem; 2016; 12(4):338-46. PubMed ID: 26548744
[TBL] [Abstract][Full Text] [Related]
15. Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.
Leung E; Cairns RA; Chaudary N; Vellanki RN; Kalliomaki T; Moriyama EH; Mujcic H; Wilson BC; Wouters BG; Hill R; Milosevic M
BMC Cancer; 2017 Jun; 17(1):418. PubMed ID: 28619042
[TBL] [Abstract][Full Text] [Related]
16. Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming.
Jin J; Qiu S; Wang P; Liang X; Huang F; Wu H; Zhang B; Zhang W; Tian X; Xu R; Shi H; Wu X
J Exp Clin Cancer Res; 2019 Aug; 38(1):377. PubMed ID: 31455352
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunction represses HIF-1α protein synthesis through AMPK activation in human hepatoma HepG2 cells.
Hsu CC; Wang CH; Wu LC; Hsia CY; Chi CW; Yin PH; Chang CJ; Sung MT; Wei YH; Lu SH; Lee HC
Biochim Biophys Acta; 2013 Oct; 1830(10):4743-51. PubMed ID: 23791554
[TBL] [Abstract][Full Text] [Related]
18. Identification of Targets of the HIF-1 Inhibitor IDF-11774 Using Alkyne-Conjugated Photoaffinity Probes.
Ban HS; Naik R; Kim HM; Kim BK; Lee H; Kim I; Ahn H; Jang Y; Jang K; Eo Y; Song KB; Lee K; Won M
Bioconjug Chem; 2016 Aug; 27(8):1911-20. PubMed ID: 27386732
[TBL] [Abstract][Full Text] [Related]
19. Celastrol inhibits the HIF-1α pathway by inhibition of mTOR/p70S6K/eIF4E and ERK1/2 phosphorylation in human hepatoma cells.
Ma J; Han LZ; Liang H; Mi C; Shi H; Lee JJ; Jin X
Oncol Rep; 2014 Jul; 32(1):235-42. PubMed ID: 24859482
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of the HIF-1α/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants.
Kluza J; Corazao-Rozas P; Touil Y; Jendoubi M; Maire C; Guerreschi P; Jonneaux A; Ballot C; Balayssac S; Valable S; Corroyer-Dulmont A; Bernaudin M; Malet-Martino M; de Lassalle EM; Maboudou P; Formstecher P; Polakowska R; Mortier L; Marchetti P
Cancer Res; 2012 Oct; 72(19):5035-47. PubMed ID: 22865452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
